|
|
|
-
Japanese encephalitis is a potentially
severe viral disease that is spread by infected mosquitoes in the agricultural
regions of Asia.
-
It is one of several mosquito-borne virus
diseases that can affect the central nervous system and cause severe complications
and death.
-
Japanese encephalitis can be a risk to
travelers to rural areas where the disease is common.
-
There is no specific treatment for Japanese
encephalitis.
1. Introduction
2. What
You Really Need to Know
3. Vaccination
against Japanese Encephalitis
1.
Introduction
WHO (World Health Organisation)
reports as many as 50,000 cases and 10,000 deaths due to Japanese encephalitis
(JE) every year. JE is endemic in many Asian countries like China,
Japan, Taiwan, Korea, Philippines, Thailand, Indonesia, Bangladesh, Sri
Lanka, Vietnam and Cambodia.
JE is also endemic in Malaysia
and occurs sporadically throughout the country all year round. Although
there has been no significant increase in JE in the last few decades, outbreaks
were reported.
2.
What You Really Need to Know
What
is Japanese Encephalitis?
JE is a disease
caused by virus transmitted through the bites of Culex mosquitoes.
How
is Japanese Encephalitis Transmitted?
-
JE cannot be spread from human
to human.
-
Eating pork cannot transmit
the disease.
-
The JE virus multiplies in the
pig's body. When the female Culex mosquito sucks the blood of pig,
she picks up the JE virus.
-
After an incubation period of
14 days, the Culex mosquito is able to transmit the JE virus to a new host
usually the pig.
The JE virus can infect human
and horses if the infectious Culex mosquitoes bit them. Human and horses
are the dead end hosts since there are no transmission from man to man
or from horse to horse.
Signs
and Symptoms of Japanese Encephalitis
Most infected persons
develop mild symptoms or no symptoms at all. In people who develop a more
severe disease, JE usually starts as a flu-like illness, with fever, chills,
tiredness, headache, nausea, and vomiting. Confusion and agitation can
also occur in the early stage. The illness can progress to a serious infection
of the brain (encephalitis) and can be fatal in 30% of cases. Among the
survivors, another 30% will have serous brain damage, including paralysis.
How
soon after Exposure do Symptoms Appear?
Symptoms usually
appear 6-8 days after the bite of an infected mosquito.
How
is Japanese Encephalitis Diagnosed?
Diagnosis is based
on tests of blood or spinal fluid.
Who
is at Risk for Japanese Encephalitis?
Anyone can get Japanese
encephalitis, but some people are at an increased risk:
-
People living in rural areas
where the disease is common
-
Travelers to rural areas where
the disease is common
How
Common is Japanese Encephalitis?
Japanese encephalitis
is the leading cause of viral encephalitis in Asia.
The disease is very rare,
however, in U.S. travelers to Asia.
The chance that a traveler
to Asia will get Japanese encephalitis is very small:
-
Only certain mosquito species
can spread Japanese encephalitis
-
In areas infested with mosquitoes,
only a small portion of the mosquitoes are usually infected with Japanese
encephalitis virus
-
Among persons who are infected
by a mosquito bite, only 1 in 50 to 1 in 1,000 will develop an illness.
As a result, fewer than 1 case per year is reported in U.S. civilians and
military personnel traveling to and living in Asia.
-
Only 5 cases among Americans
traveling or working in Asia have been reported since 1981.
Habits
of Mosquitoes Carrying Japanese Encephalitis
-
Only the Culex mosquitoes can
transmit the JE virus.
-
The Culex mosquitoes breed in
dirty polluted water such ponds, pools, ditches, puddles, drains and rice
fields.
-
Culex mosquitoes bite between
dawn and dusk (6.30pm - 6.30am).
-
Culex mosquitoes prefer pig
rather than human blood.
Ways
of Preventing Japanese Encephalitis
-
Avoid being bitten by mosquito
-
Sleep in mosquito net
-
Using insecticides to prevent
insect bites (e.g. mosquito coil, repellent, aerosol spray and cream)
-
Fixing wire netting at all windows
-
Wear long sleeved clothes /
trousers
-
Eliminating all Culex breeding
places
-
Providing good and proper drainage
system
-
Drain or fill up all pools and
puddles with sand
-
Maintain cleanliness in the
piggeries
-
Conduct regular fogging exercise
in and around the pig farms.
Who
requires Vaccination against Japanese Encephalitis
-
Workers in the pig farms
-
People staying in or near the
pig farms up to a radius of 2 km, especially children.
3.
Vaccination against Japanese Encephalitis
Introduction
JE is the leading
cause of viral encephalitis in Asia. In endemic areas, annual incidence
of clinical disease ranges from 10-100 per 100,000 population. Case
fatality average 30% and a very high percentage of the survivors are left
with permanent neuropsychiatric sequelae.
There is no efficient drug
treatment for this disease. In recent decades the JE virus has caused epidemics
in previously unaffected countries, including India, Myanmar, Nepal, Sri
Lanka, Thailand and Vietnam.
No effective method of environmental
control of JE transmission is known. Although socioeconomic improvement
and changes in agricultural practices are likely to reduce viral transmission
in some places, large - scale vaccination of affected populations with
effective and affordable vaccines appears to be the logical control measures,
at least in the short term.
The impact of large-scale
JE vaccination is clearly documented in some regions of China, and systematic
vaccination has also contributed significantly to the declining incidence
rates in Japan, Republic of Korea and Thailand.

Types
of Vaccines
Three types of JE
vaccine are currently in large - scale production and use, namely:
-
Mouse brain - derived inactivated
vaccine
-
Cell culture - derived inactivated
vaccine and
-
Cell culture - derived live
attenuated vaccine
The mouse brain - derived
and inactivated vaccine based on the Nagayama strain (or Beijing - 1 strain)
is currently the only vaccine available on the international market. China
produces two JE vaccines for domestic use, an inactivated JE as well as
a live attenuated vaccine, both grown in primary hamster kidney cells.
Controlled studies have shown
that the commercially available mouse brain-derived vaccine is efficacious
and without serious side effects for childhood vaccination. Local
reactions such as tenderness, redness and swelling occur in 20% of vaccines.
A similar percentage may experience mild systemic symptoms, including headache,
myalgia, gastro-intestinal symptoms and fever.
The mouse brain - derived
vaccine is given subcutaneously in doses of 0.5ml or 1ml, the lower dose
being for children aged 1-3. The manufactures recommended that 2 injections
be given at an interval of 1-2 weeks in primary immunization followed by
a booster after 1 year, with subsequent boosters every 3-4 years to maintain
immunity.
In several Asian trials,
primary immunization has been a disease-preventing efficacy of 95%; 91%
efficacy was achieved in a placebo - controlled trial.

Contraindications
No serious permanent
side effects are known to be associated with the vaccine. Fever and local
reactions such as redness, swelling and pain are reported in fewer than
10% of those vaccinated.
There are some contraindications
to the vaccine. The manufacturer recommends that the vaccine not be administered
to the following persons:
-
Those acutely ill or with active
infections
-
Persons with heart, kidney,
or liver disorders
-
Persons with generalized cancerous
malignancies such as leukemia, lymphoma
-
Persons with a history of hypersensitivities
-
Pregnant women.
Population
at risk and dosage for vaccination
Very high
risk population
-
Pig farmers and their families
staying on the farm
-
Dose: Day 0, Day 7, Day 30,
Year 1
-
Booster: after every 3 years
High risk group
-
All those staying within 2 km
from the pig farms and below 15 years of age
-
Dose: Day 0, Day 7, 1 Year
-
Booster: after every 3 years
Payment
for vaccination
The Ministry
of Health will bear the cost incurred to vaccinate high-risk group.
This
fact sheet, compiled from various sources, is for information only and
not meant to be used for self-diagnosis or as a substitute for consultation
with a health-care provider. If you have any questions about the disease
described above, consult a health-care provider.
Viral
Encephalitis BattleGround
Kuala Lumpur, March 17,
1999
Please
circulate to fellow Malaysians.
Mosquitoes do not discriminate who they bite.
|
|
CHECK OUT
Strategic
Library
NOW!
|